naaccr irb approved studies · lisa paddock passive ... 16‐09 1995‐2013 analysis of cancer...
TRANSCRIPT
NAACCR IRB Approved Studies
Active Studies:
05‐13 1995‐2002 2006‐Cutaneous malignant melanoma (CMM): Differences in epidemiology between U.S. adults and children, 1995‐2002
Lisa Paddock Passive
07‐05 continuous 2007 ‐ Projecting estimates of cancer incidence for every US state both spatially and temporally. [This is an annual project for American Cancer Society's Facts and Figures.]
Rebecca Seigel (formerly Ahmedin Jema Passive
13‐01 1998‐2010 Delayed for Survival Data 2013‐Ovarian cancer mortality and survival trends in relation to changing patterns of menopausal hormone therapy in the United States ‐ Delayed for Survival Data
Hannah Yang and Mark Sherman Active
13‐02 1998‐2010 2013‐Trends in hormone related female cancer incidence in relation to changing patterns of menopausal hormone therapy in the United States
Mark Sherman and Hannah Yang Passive
13‐05 2005‐2009 2013‐Health insurance and cancer stage at diagnosis Xuesong Han Active
13‐09 1995‐2011 2013‐The burden of cancer in the USA in 2012 by race/ethnicity
Joannie Lortet‐Tieulent (ACS) Passive
Friday, October 13, 2017 Page 1 of 24
14‐03 1995‐2012 2014‐Geographic clustering of invasive melanomas in the United States
Phyllis Gimotty (University of Pennsylva Active
14‐10 1995‐2011 Examining cancer disparities in the Philadelphia Metro Area (New Jersey, Pennsylvania and Delaware)
Kevin Henry Active
15‐05 1995‐2012 Testicular cancer incidence in men aged 50 years and older Armen Ghazarian Passive
15‐06 1995‐2012 Assessing the relationship between rural‐urban residence and cancer using the NAACCR urban‐rural indicator codes
Kevin Henry, Recinda Sherman Passive
15‐10 1995‐2012 Rates of childhood cancers in the US Meredith Shiels, NCI Passive
15‐11 1995‐2012 The association between the incidence of Chronic Lymphocytic Leukemia among adults in the US and rural‐urban residence
S. Cristina Oancea, NDSCR Passive
15‐13 ON HOLD not yet approved by RApR; waiting response from researcher
Chaturvedi ON HOLD RE
Friday, October 13, 2017 Page 2 of 24
15‐14 1995‐2013 Socioeconomic status and variaton in laryngeal cancer stage at diagnosis and survival: a cross‐country comparison
Eshwar Kumar Active
16‐01 1995‐2013 Trends in incidence rates of biliar tract cancers by age group and cancer site among adults in North America and associations with trends in obesity rates
Alison VanDyke Active
16‐02 1995‐2013 Trends in incidence of esophageal and gastric cancer by histological/anatomical subtype and race in the US
Jemal Passive
16‐03 1995‐2013 Incidence of hepatocelluar carcinoma and intrahepatic cholangiocarcinoma by racial/ethnic group in the US
Katherine McGlynn Passive
16‐04 1995‐2013 Imputing hormone receptor and HER2 status for defining breast cancer molecular subtypes using US population based cancer registry data
Nadia Howlader Active
16‐05 1995‐2013 PENDING RESPONSE FROM RESEARCHER/UNDERGOING IRB REVIEW: The Affordable Care Act and cancer stage at diagnosis
Xuesong Han Active
16‐06 1995‐2013 Geographic patterns in lung cancer incidence in the US Denise Lewis Active
Friday, October 13, 2017 Page 3 of 24
16‐07 1995‐2013 Age‐ and subsite‐specific trends in incidence of gastric and esophageal cacners in North American adults
M. Constanza Camargo Active
16‐08 1995‐2013 Forecast of trends in esophageal and gastric cancer in the US through 2030
Jessica Petrick Active
16‐09 1995‐2013 Analysis of cancer among transsexual and intersex patients in the US using national surveillance data
Kevin Ward & Michael Goodman Passive
16‐10 1995‐2013 Measuring observed incidence of prostate cancer by grade and extent of disease for race/ethnic groups in the US and Canada
Raymond Balise Passive
16‐11 1995‐2013 Oregon Hereditary Cancer Surveillance Kristin Kane & Alicia Parkman Active
16‐12 1995‐2013 State‐level lung cancer burden Dennis Deapen & Zach Jump Active
16‐13 1995‐2013 Geographic Patterns in incidence of TNBC Tatalovich Wenzel & Moss Active
Friday, October 13, 2017 Page 4 of 24
16‐14 1995‐2013 Determining the extent of head & neck cacner outcome disparity in Appalachia
Scott Weed Passive
17‐02 1995‐2014 Disparities in breast cancer subtype, stagin, and access to mammography in the Mississippi Delta Region
Whitney Zahnd Active
17‐03 1995‐2014 UNDERGOING RApR Review: Evaluation of breast cancer treatmetn patterms among Medicare Patients in Appalachia
Faustine Williams & Iris Zachary Active
17‐04 1995‐2014 County‐level variations and factors contributing to variations in receipt of curative‐intent surgery for early‐stage, non‐small cell lung cancer (NSCLC) in US
Helmneh Sineshaw Active
17‐05 1995‐2014 Breast cancer subtypes in US women by place of birth Carol DeSantis Passive
17‐06 1995‐2014 waiting for PI to resubmit to RApR: Comparison of High‐Income White Americans and 13 Developed Countries on Cancer, Infant and Maternal Mortality, Ischemic Heart Disease and Stroke
Ezekiel Emanuel Active
17‐07 1995‐2014 waiting for PI to submit IRB materials: Circadian disruption and cancer incidence US
Neil Caporaso Active
Friday, October 13, 2017 Page 5 of 24
1995‐1999 2003‐Changing proportions and age‐specific incidence rates of epithelial vs. non‐epithelial cancers from adolescence to adulthood.
Xiaocheng Wu
1995‐2000 2003‐Urban‐rural variations in Hispanic cancer incidence. Susan Carozza, PhD and CRWG
1995‐2000 2003‐Determining Probabilities of error from each step of indirect identification method for Hispanic persons using NHIA.
Susan Carozza, PhD and CRWG
1995‐2000 2004‐Incidence of Cutaneous Melanoma in Non‐White Population in the United States, 1995‐2000.
Steven Roffers (Emory University), Xiao‐
1995‐2000 2004‐February Consent Hispanic Data Set. Steven Roffers
1992‐1997 2002‐Geographic and Racial Variations in Female Breast Cancer Incidence Rates and Stage Distributions
Mary Hutton
1995‐1999 2002 ‐ Assesment of melanoma incidence: Phase II data quality assessment.
Irene Hall
Friday, October 13, 2017 Page 6 of 24
Terminated Studies:
1994‐1998 2002‐Breast Cancer Monograph: Focus on Race/Ethnic Variations
Holly Howe and Rachel Jean‐Baptiste
1995‐2000 2004‐February consent including topography. Catherine Coreea, and Xiao Wu
1995‐1999 2002 ‐ Geographic variation in stage at diagnosis of prostate cancer and its association with the mortality patterns in the U.S.
Ahmedin Jamal
1995‐1999 2003‐Geographic variation in stage at diagnosis of prostate cancer and its association with the mortality patterns in the U.S.
Admedin Jamal
1995‐1999 2003‐In‐class exercise for the Cancer Surveillance Institute in January, 2003. No table output will be used to generate any report or paper.
1995‐2000 2004‐In class project in order to describe the cancer burden for the United States for lung cancer. Students will be given access for two days (Jan. 28th and 29th) to study and present the data to the rest of the class.
1994‐1998 2001‐To produce and publish the mongraph, Cancer in North America.
Friday, October 13, 2017 Page 7 of 24
2001 2001‐For inclusion of registry‐specific desease rates for the 2001 Annual Report to the Nation, on the burden of cancer.
2001 2001‐CINA+ Online if the data meets the standard established for high quality.
2001 2001‐The DEPC members to use these data for special analyses and data evaluation projects.
1995‐2000 2004‐Descriptive epidemiology of Paget disease of the breast, US, 1995‐2000. Project to add the use of the primary site variable by topography code in addtion to SEER groupings.
Joellyn Ellision, MPH, NAACCR
1995‐2000 2004‐Recent time trends in the incidence of selected cancers among rural and urban US populations, 1995‐2000.
Robert Greenlee
1995‐2001 2005‐Geographic variations in breast cancer incidence in the U.S.
Carol Smigal, Ahmedin Jemal, American Active
03‐01 1995‐1999 2003‐Urban‐rural variation in the incidence of selected cancer sites, United States, 1995‐1999.
Holly Howe
Friday, October 13, 2017 Page 8 of 24
03‐02 1995‐2000 2003‐Mini‐Proposal: Urban‐Rural Incidence Gradient in Childhood Leukemia.
Frank Groves
03‐03 1995‐1999 2003‐Quality assessment and use of CINA Deluxe Morphology Data.
William Athas
03‐04 1995‐2000 2003‐Incidence of Noncutaneous Melanomas in the United States.
Colleen Mclaughlin
03‐05 1995‐2000 2003‐2004 Hispanic Call for Data Monograph Holly Howe
03‐06 1995‐1999 2003‐Subsite‐specific Colorectal Cancer Incidence Rates and Stage Distributions in Asian/Pacific Islanders, Whites, and Blacks in the US, 1995‐1999
Xiaocheng Wu
03‐07 1995‐2000 2004‐Subsite and morphology of esophageal and gastric cancers in the United States, 1995‐2000.
Xiao‐cheng Wu, Vivien Chen, Bernardo
03‐08 1995‐2000 2004‐The epidemiology of breast cancer among men in the United States, 1995‐2000.
Marc T. Goodman
Friday, October 13, 2017 Page 9 of 24
03‐09 1995‐2000 2004‐Obtaining further evidence of the reported decrease in distant stage disease for prostate cancer.
Ben Hankey‐retired/Denise Lewis
03‐10 1995‐2000 2004‐Descriptive Epidemiology of Pancreatic Cancer in the United States, 1995‐2000.
Catherine Correa, L. Joseph Su, Elizabet
03‐11 1995‐2000 2004‐Projecting estimates of cancer incidence for every US state both spatially and temporally.
Linda Pickle‐retired/Barnali Das
03‐12 1995‐2000 2004‐Trends in thyroid cancer histologic sub‐types in the United States.
Karen Pawlish
03‐13 1995‐2000 2004‐Developing new methodology for estimating the completeness of case ascertainment.
Barnali Das, Linda Pickle
03‐14 1995‐2000 2004‐Geographic Patterns of Prostate Cancer Mortality in the U.S. in Relation to Variations in the Stage and Grade at Diagnosis.
Ahmedin Jemal
03‐16 1992‐1997 2003‐Evaluation of Methods to Estimate and Compare Race/ethnicity specific Cancer Incidence Rates Using Combined Central Cancer Registry Data.
Robert Greenlee
Friday, October 13, 2017 Page 10 of 24
04‐01 1995‐2001 2004‐Descriptive epidemiology of Paget disease of the breast, US, 1995‐2001. Note: updated data set.
Joellyn Ellison
04‐02 1995‐2000 2004‐Cancer Incidence Among Hispanic/Latino Children and Adolescents.
Sue Carozza
04‐02 1995‐2000 2003‐Cancer Incidence among Hispanic children and Adolescents.
Susan Carozza
04‐03 1995‐2000 2004‐Comparison of trends in infant neuroblastoma and other cancers in the United States, 1995‐2000.
Lisa Roche, Betsy Kohler
04‐03 1995‐2001 2004‐Comparison of trends in infant neuroblastoma and other cancers in the US, 1995‐2001.
Lisa Roche‐retired/Betsy Kohler
04‐04 1995‐2000 2004‐Incidence of Chronic Lymphocytic Leukemia by Racial and Ethnic Group in the United States, 1995‐2000.
Marc T. Goodman
04‐05 1995‐2001 2004‐Recent time trends in the incidence of selected cancers among rural and urban US populations, 1995‐2001. Note: updated data set.
Robert Greenlee
Friday, October 13, 2017 Page 11 of 24
04‐06 1995‐2000 2003‐Geographic variation in cancer incidence among Hispanic populations.
Maria Schymura
04‐07 2004‐Assessment of development of name lists for Asian groups.
Holly Howe
04‐08 1995‐2001 2004‐Incidence of Cutaneous Melanoma in the US by Race, Age, and Anatomic Subsite, 1995‐2001.
Lisa Roche‐retired/Xiaocheng Wu
04‐09 1995‐2001 2004‐Using NAACCR Data to Validate Cancer Prevalence at the State Level.
Angela Mariotto
04‐10 1995‐2001 2004‐Distributions and incidence rates of subsite‐specific leukemia in Asians/Pacific Islanders and other racial populations in the U.S.
Xiaocheng Wu
04‐11 1995‐2001 2004‐Demographic characteristics of individuals diagnosed with head and neck cancers.
Marsha Reichman
04‐12 1995‐2001 2004‐Risk of Childhood Cancers Associated with Residence in Agriculturally Intense Areas of the U.S.
Sue Carozza
Friday, October 13, 2017 Page 12 of 24
05‐01 1995‐2001 2005‐Variation in Cancer Stage at Diagnosis by Area‐Level Poverty and Urban/Rural Gradient in CINA Deluxe 1995‐2001: A NAACCR 'Access to Care' Special Study.
Robert Greenlee
05‐02 1995‐2002 2005‐Geographic variations in breast cancer incidence in the United States. Note: updated data set.
Carol Smigal, Ahmedin Jemal Active
05‐03 1995‐2002 2005‐Subsite and Histology of Esophageal and Gastric Cancers among Hispanics and non‐Hispanics in the U.S, 1995‐2002.
Xiaocheng Wu
05‐04 1995‐2002 2005‐Racial Disparities in Esophageal Cancer Incidence and Potential Influences of Data Integrity in Results.
Emmanuel Nwokolo
05‐05 1995‐2002 2005‐Carcinoma of the Biliary Tract in the United States. Marc T. Goodman Passive
05‐06 1995‐2002 2005‐Comparative Epidemiologic Patterns of Leukemia among Men and Women in the United States.
Marc T. Goodman Active
05‐07 1995‐2003 ARN on the status of cancer 1975‐2003, with a special feature on cancer in US Hispanic/Latino populations, 1999‐2003
Holly Howe
Friday, October 13, 2017 Page 13 of 24
05‐08 1995‐2002 2006‐Solar Radiation and Cancer Incidence and Mortality in North America.
Frank Boscoe Active
05‐09 1995‐2003 2006‐Epidemiology of Head and Neck Cancer in the U.S. Colleen McLaughlin
05‐10 1995‐2002 2006‐Geography of second primary breast cancer. Jeanette Jackson‐Thompson Passive
05‐11 1995‐2002 2006‐Spatio‐temporal estimation of cancer incidence in all US states for 1995‐2002
Linda Pickle Active
05‐11 1995‐2003 2006‐Spatio‐temporal estimation of cancer incidence in all US states for 1995‐2002.
Linda Pickle Active
05‐12 1995‐2002 2006‐Cancer Incidence Disparities in Applalachia and within Appalachian Sub‐regions.
Bin Huang Active
05‐14 1995‐2002 2006‐General Assessment of Rare Cancers in CINA Deluxe 1995‐2002
Robert Greenlee Passive
Friday, October 13, 2017 Page 14 of 24
05‐15 1995‐2002 2006‐Descriptive Epidemiology of Invasive Primary Cardiac Tumors.
Robert Greenlee Passive
06‐01 1998‐2002 2006‐Quality and Correction of Time Trend Estimates in the Presence of Missing Data in CINA Deluxe.
Robert Greenlee Passive
06‐02 1995‐2004 2006‐Analysis of AI/AN Data from NAACCR Data Submissions for the 2007 Annual Report to the Nation.
Holly Howe
06‐03 na 2006‐Testing Record Consolidation of the New Multiple Primary/Histology Rules.
Holly Howe/Betsy Kohler
06‐04 1995‐2003 2006‐Incidence rates and trends for chronic myeloproliferative disorders and myelodysplastic syndromes.
Matthew Hayat‐no longer a member/Ly
06‐05 1995‐2003 2006‐Ecologic Method to Estimate Specific Latino Group Cancer Rates.
Holly Howe
06‐06 2006‐Epidemiology of Penile Carcinoma in the United States, 1995‐2003.
Marc T. Goodman
Friday, October 13, 2017 Page 15 of 24
06‐07 2006‐Incidence patterns of primary extranodal Non‐Hodgkin lymphoma by anatomic site and histology among whites, blacks, and Asians and Pacific Islanders (API) in the U.S.
Xiaocheng Wu
06‐08 2006‐Racial/ethnic differences in national incidence trends of primary, invasive cervical cancer.
Jill Barnholtz‐Sloan‐no longer a member
07‐01 2007‐Multiple Imputation for Incomplete Cancer Registry Data.
Brent J. Shelton
07‐02 1995‐2004 2007‐Trends in colorectal cancer incidence rates by county‐level poverty in the US, 1995‐2004
Yongping Hao
07‐03 2007‐Quantifying transportation barriers in accessing health facilities for breast cancer diagnosis and treatment
Holly L. Howe ‐ no longer the PI/ Charlie
07‐04 2007‐Highlights from CINA 2000‐2004 Holly L. Howe
07‐06 2007 ‐ Geographic Patterns of Cervical Cancers in the US: Incidence, Mortality, and Related Factors
David Stinchcomb
Friday, October 13, 2017 Page 16 of 24
07‐07 2007 ‐ Racial/ethnic and socioeconomic variation in breast cancer incidence trends: US and Canada, 1995‐2004
Christina Clarke
07‐08 2007 ‐ Comparative Incidence of Fallopian Tube Cancer, Primary Peritoneal Cancer, and Ovarian Cancer in the US, 1995‐2004
Marc T. Goodman
07‐09 2007 ‐ Incidence of Soft Tissue Sarcoma in Older Adolescent and Young Adults, US, 1995‐2004
Mei‐Chin Hsieh
08‐01 2008 ‐ Multiple Imputation for Incomplete Cancer Registry Data
Brent Shelton
08‐03 2008 ‐ Evaluation of in situ Tumors Reported to Cancer Registries
Holly L. Howe
08‐04 2008 ‐ Epidemiology of Head and Neck Cancer Sub‐sites among Different Racial and Ethnic Populations in the United States, 1995‐2005
Edward Peters
08‐05 2008 ‐ Hematopoietic Cancers in the Hispanic Population in the United States
Maria Schymura
Friday, October 13, 2017 Page 17 of 24
09‐01 2009 ‐ Pediatric Brain Tumor Incidence: Comparison of the Central Brain Tumor Registry of the United States (CBTRUS) and the International Classification of Childhood Cancer, Third Edition (ICCC‐3) Classification Schemes
Bridget J. McCarthy
09‐02 2009 ‐ Spatio‐temporal estimation of childhood cancer incidence in all US states for 1995‐2009
Li Zhu
10‐01 2010 ‐ Urban‐Rural Gradient and Time Trends in Incidence of Medulloblastoma
Frank D. Groves
10‐02 1995‐2007 2010 ‐ Comparative Epidemiology of Osteosarcoma in Adults Holly L. Howe Passive
10‐03 2010 ‐ 3 State/3 Province Combined Cancer Incidence Rate Study ‐ A Descriptive Epidemiology Study
Bruce Riddle Active
10‐04 2010 ‐ Cancer in the Appaliachian Regions of North Carolina, Tennessee, and Virginia, 2004‐2006
Toni Herring Bounds ‐ retired
10‐05 1995‐2007 2010 ‐ Incidence of Small Bowel Cancer in the United States, 1995‐2007
Marc T. Goodman Passive
Friday, October 13, 2017 Page 18 of 24
10‐06 1995‐2007 2010 ‐ Recent Changes in Incidence Rates of Ovarian Cancer: Relationship to Patterns of Use of Hormone Replacement Therapy
Mark E. Sherman NCI Passive
10‐07 1995‐2007 2010 ‐ Comparison of Patients Captured in the National Cancer Data Base with Those in Population‐Based Central Registries
Anthony Robbins Active
11‐01 1995‐2007 2011 ‐ Geographic Association of Agriculture and Pancreatic Cancer
Brian Luckett Active
11‐02 1999‐2008 2011 ‐ Comparisons of Cancer Incidence and Mortality for Rural vs. Urban Counties in Pennsylvania and Rural United States
Samuel Lesko Active
11‐03 2004‐2007 2011 ‐ Data Quality Control Through Nonlinear Association Analysis of Unknown Staged Cancer Cases
Qingzhao Yu Active
11‐04 1995‐2008 2011 ‐ Hodgkin Lymphoma Incidence in the United States by Age, Race, and Ethnicity
Denise Lewis Passive
11‐05 1995‐2008 2011 ‐ Estimating Complete Prevalence by State/County Angela Mariotto Active
Friday, October 13, 2017 Page 19 of 24
11‐06 1995‐2008 2011 ‐ Incidence and Trend of Soft Tissue Sarcoma in Adolescents and Young Adults
Mei‐Chin Hsieh Active
11‐07 2004‐2008 2011‐Comparing Surveillance Methods Using County‐level Cancer Incidence Data in the United States
Ge Lin Active
11‐08 1999‐2008 2011‐State‐specific Endometrial Cancer Incidence Rates Corrected for Hysterectomy Prevalence
Rebecca Siegel Passive
12‐01 1995‐2009 2012‐U.S. geographic distribution of hepatocellular and cholangiocarcinoma
Zaria Tatalovich Active
12‐02 2005‐2009 2012‐Assessing the relationship between poverty and cancer using the census tract poverty indicator
Frank Boscoe Active
12‐03 1995‐2009 2012‐Analysis of ethnic disparities in colon cancer suggests a potential need for early colon cancer screening in Asians living in the USA
Jeannette Jackson‐Thompson Passive
12‐04 2004‐2009 2012‐Weighting method to handle missing values in estimating tumor stage distributions in population‐based cancer registration
Qingzhao Yu Active
Friday, October 13, 2017 Page 20 of 24
12‐05 1995‐2009 2012‐Priorities for cervical cancer control based on disparities in race, social position, screening, vaccination, incidence, and mortality, 1995‐2009
Sean Alterkruse (Jonathan Kish) Active
13‐03 2000‐2010 2013‐Cancer burden and trends among adults aged 20‐40 years in the U.S.
Edgar Simard Passive
13‐04 1998‐2010 2013‐Insurance coverage expansion and disparities in cervical, prostate, and lung cancer
Amresh Hanchate Passive
13‐06 2013‐Withdrawn before IRB approval WITHDRAW
13‐07 2005‐2010 2013‐Female breast cancer incidence at Komen Foundation affiliate‐level
Serban Negoita Active
13‐08 2001‐2010 2013‐State‐level changes in the incidence of HPV‐associated anal and oropharyngeal cancers in the US
Edgar Simard Passive
14‐02 1995‐2011 2014‐Comparison of latitude gradients for testicular cancer and remaining cancer in Australia and the United States
Peter Baade (Cancer Council Queenslan Active
Friday, October 13, 2017 Page 21 of 24
14‐04 1995‐2011 Recent trends in incidence of testicular germ cell tumors in the US: rising rates among Hispanic men
Armen Ghazarian (NCI Fellow) Passive
14‐05 1995‐2012 The epidemiology of pediatric brain cancers in Appalachia Bin Huang Active
14‐06 1995‐2011 Variations in receipt of curative‐intent surgical treatment for early‐stage non‐small cell lung cancer (NSCLC)
Helmneh Sineshaw Active
14‐07 1995‐2012 Lymphoid malignancy statistics in the US, 2001‐2012 Jemal & Teras Passive
14‐08 1995‐2012 Demographic and regional/state variation in DCIS and early stage breast cancer incidence and treatment
Ward & Lin Passive
14‐09 NOT APPROVED by RApR
15‐01 1995‐2012 Recent trends in incidence of testicular germ cell tumors in the US
Armen Ghazarian Passive
Friday, October 13, 2017 Page 22 of 24
15‐02 1999‐2012 WITHDRAWN: pending IRB materials from PI: Maine Cancer Registry: Annual Cancer Report and Routine Surveillance using CINA deluxe data
Molly Schwenn Passive
15‐03 1995‐2012 US CONCORD‐2 study: incidence rates (1995‐2009) Hannah Weir Passive
15‐04 1995‐2012 WITHDRAWN: The impact of reporting practices onstate and local lip cancer rates
Frank Boscoe, Christopher Johnson WITHDRAW
15‐07 1995‐2012 Forecasting trends in testicular germ cell tumors in the US Armen Ghazarian, NCI Active
15‐08 1995‐2012 NOT APPROVED by RApR: Spatial analysis of rural disparities in staging and oncologic outcomes for esophageal and pancreas cacner
Whitney Zahnd, SIUSM NOT APPRO
15‐09 1995‐2012 NOT APPROVED by RApR: The association between environmental radon exposures and long term survival from Chronic Lymphocytic Leukemia among adults in the US
S. Cristina Oancea, NDSCR NOT APPRO
15‐12 1995‐2012 WITHDRAWNPending revision of application by PI: Treatment pattenrs in Primary CNS Lymphoma
Mendel Goldfiner/Kevin David, Rutgers WITHDRAW
Friday, October 13, 2017 Page 23 of 24
17‐01 1995‐2013 Recalibrating NHIA‐‐UPDATE under Primary Data Uses for Workgroup data evaluation
Frank Boscoe Passive
Friday, October 13, 2017 Page 24 of 24